Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Mefesaph - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Mefesaph

Approved

STANDARD

Mefesaph

Sapphire Lifesciences Pvt. Ltd.🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 010ab826ae977c68
Company: Sapphire Lifesciences Pvt. Ltd.
Type: Standard

Approval Details

Approval Id: 010ab826ae977c68
Drug Approval Philippines Name: Mefesaph
Product Name: Mefesaph
Registration Number: DRP-5836
Brand Name: Mefesaph
Generic Name: Mefenamic Acid
Dosage Form: Tablet
Dosage Strength: 500 mg
Manufacturer: Sapphire Lifesciences Pvt. Ltd.
Importer: Nelpa Lifesciences, Inc.
Distributor: Nelpa Lifesciences, Inc.
Issuance Date: 28 September 2024
Expiry Date: 04 December 2029
Pharmacologic Category: Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification: Over-The-Counter (OTC)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

010ab826ae977c68

Type

Standard

Back to Philippines FDA Approvals